Hotline: 1800 102 2007
Hotline: 1800 102 2007
Mar, 07 2017

To streamline business Cipla sells its animal health business to Ascendis for Rs 190 crore

Cipla's animal health division operates mainly in the farm animal segment and its main products include antimicrobials, endectocides, proton pump inhibitors, non-steroidal anti-inflammatory drugs, and supplements.

To streamline business Cipla sells its animal health business to Ascendis for Rs 190 crore

Drug manufacturer Cipla has sold its animal health business in South Africa to Ascendis Health for around Rs 190 crore as part of its strategy to streamline business and focus on core therapies.

Cipla's animal health portfolio, which exists in India and Africa, contributes less than one per cent to the company's consolidated revenue.

The drug maker said it had signed an agreement to divest its 100 per cent stake in two South African entities — Cipla Agrimed and Cipla Vet.

The total consideration of the transaction would be 375 million South African Rand (around Rs 190 crore) with potential revision linked to the performance in financial year 2017 (within the price band of 250 million Rand and 500 million Rand).

Cipla's animal health division operates mainly in the farm animal segment and its main products include antimicrobials, endectocides, proton pump inhibitors, non-steroidal anti-inflammatory drugs, and supplements.

In a statement, Cipla South Africa CEO Paul Miller said that the company will increase its focus and efforts in advancing healthcare for all South Africans and will grow its portfolio of quality and affordable products and therapies.

The sale of the animal health business is in line with the company's strategy to cut down on non-core businesses and focus on key areas, including the respiratory segment.

Its key markets include India, South Africa and the US. Last year, it exited from several markets to reduce costs and complexities and also sold its stake in clinical stage biopharmaceutical company Chase Pharmaceuticals to Allergan.

From Cipla’s folio India, US and South Africa key markets for Cipla. Account for over 70 per cent of revenue Sale of animal health business is in line with the focus being on key therapy areas such as respiratory Cipla is exiting non-core businesses to reduce costs and complexities Animal health business contributes to less than one per cent of Cipla’s consolidated revenue

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Casual Dine Restaurants
    For more than six and a half decades, Prabhuji Pure..
    Locations looking for expansion West bengal
    Establishment year 1950
    Franchising Launch Date 2020
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Kolkata West bengal
  • Quick Service Restaurants
      Format Investment Brand Fee Space Staff Exp. Monthly Sales ..
    Locations looking for expansion Uttar pradesh
    Establishment year 2016
    Franchising Launch Date 2017
    Investment size Rs. 5lac - 10lac
    Space required 200
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Lucknow Uttar pradesh
  • Bike Maintanance & Repair Services
    ·         The Flyer Tech Automobiles has been estab..
    Locations looking for expansion Haryana
    Establishment year 2016
    Franchising Launch Date 2019
    Investment size Rs. 5lac - 10lac
    Space required 1000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Gurgaon Haryana
  • Preschools
    About Us: Pre School Franchise is a recession free business and..
    Locations looking for expansion Karnataka
    Establishment year 2017
    Franchising Launch Date 2019
    Investment size Rs. 10lac - 20lac
    Space required 1500
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities